Home / Stocks / ATHE

ATHE insider trading

ALTERITY THERAPEUTICS LTD — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
2
Bought · 24 mo
$71k
Buys · last 90 days
2 · $71k
Most recent buy
2026-09-08

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-09-08Marks Peter Ashley
Director
Bought95,240$0.50$48k
2026-09-08Stamler David Allen
Chief Executive Officer
Bought47,620$0.50$24k

Most active insider buyers

InsiderRoleBuysTotal bought
Marks Peter AshleyDirector1$48k
Stamler David AllenChief Executive Officer1$24k

See ATHE on the chart

Every insider buy and sell for ATHE plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.